Global Uveitis Treatment Market, by Treatment (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungals, and Analgesics), by Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Panuveitis), by Cause (Infectious Uveitis and Non-infectious Uveitis) and by Region - Trends and Forecast to 2025

Uveitis Treatment Market – Insights

Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20–50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type. The other two types include intermediate uveitis and posterior uveitis that affects the posterior choroid part of the uvea. Uveitis can be treated with the help of various drugs that include corticosteroids, immunosuppressant, monoclonal antibodies, analgesics, and drug formulations.

Rise in development of innovative biologics is expected to accelerate growth of the market

Primary driving factor contributing towards growth of the uveitis treatment market is rising incidence of uveitis. According to a study by American University of Beirut Medical Center in 2015, Uveitis is responsible for 10% of legal blindness in the U.S. and up to 25% of blindness in the developing countries. Moreover, according to a study conducted by F. I. Proctor Foundation, University of California, San Francisco in 2013 suggested that uveitis incidence rate among the U.S. population could be approximated to 24.9 cases per 100,000 people. In addition to this, several other factors driving growth of the market include rise in healthcare expenditure for treatment development and development of new and innovative biologics for uveitis treatment. However, factors limiting growth of the market include side effects such as kidney damage, high blood sugar, and osteoporosis due to immunosuppressant drugs. Moreover, complications associated with the medication could result in irreversible blindness, which is a major factor limiting the market growth.

The global uveitis treatment market was valued at US$ 555.51 Mn in 2016 and is expected to exhibit a robust CAGR of 6.0% over the forecast period (2017–2025).

Figure 1. Global Uveitis Treatment Market Value (US$ Mn), by Region 2016

uveitis treatment market

Source: Coherent Market Insights (2017)

Speedy FDA approvals for uveitis treatment drugs to propel the market growth      

A large number of new as well as established companies are focusing on development of drugs for the treatment of uveitis in various forms such as monoclonal antibodies, immunosuppressant, corticosteroids, anti-fungal agents, anti-viral agents, and others. FDA is focusing on speedy drug approval process as uveitis has serious ill effects leading to disorders such as glaucoma and permanent blindness. This creates a highly conducive environment for market players to invest in research and development activities to file for patents as well as develop generic biologics for treating this disorder. According to the Regulatory Affairs Professionals Society, FDA has approved around 38 generic drugs till July 2017.

Asia Pacific is expected to witness a significant growth in the global uveitis treatment market and this can be attributed to increasing number of regional players focusing on development of biologics for the treatment of uveitis. For instance, Santen Pharmaceuticals received U.S. FDA approval for its new drug in April 2017, for the treatment of non-infectious uveitis of the posterior segment.

Some of the major players operating in the uveitis treatment market are AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences.

Uveitis refers to an autoimmune eye disease that causes inflammation in the uvea of the eye. Uveitis is considered to be one of the leading cause of blindness in the U.S. According to the Ocular Immunology and Uveitis Foundation in 2016, Uveitis is the third leading cause of blindness in the U.S. having affecting approximately 38 cases per 100,000 population. The three common types of uveitis are anterior uveitis (swelling of the uvea towards the front of the eye), intermediate uveitis (swelling in the middle of the eye), and posterior uveitis (swelling of the uvea towards the back of the eye). Panuveitis refers to a case in which all three areas of the eye are affected by inflammation. The most common type among the three is the anterior uveitis.

Market Dynamics

Major factors driving growth of the global uveitis treatment market include rising incidence of uveitis and complications associated with the disease. According to a survey published in research journal of JAMA Ophthalmology, non-infectious uveitis was reported in 121 cases per 100,000 adults and 29 per 100,000 children in 2016. Various other factors supporting the market growth include rising expenditure in research and development for new therapies to treat uveitis as well as speedy approvals from U.S. FDA for the drugs in pipeline to treat the condition. However, factors such as irreversible blindness in some cases due to side effects of medications and other such medical conditions can thus, hinder the market growth for global uveitis treatment. The side effects associated with corticosteroids include high blood pressure, kidney damage, skin disorders, and others.

Key features of the study:

  • This report provides in-depth analysis of uveitis treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the uveitis treatment Market

Detailed Segmentation:

  • Global Uveitis Treatment Market, By Treatment:
    • Corticosteroids
    • Immunosuppressants
    • Monoclonal Antibodies
    • Cycloplegic Agents
    • Antibiotics
    • Antifungals
    • Antivirals
    • Analgesics
  • Global Uveitis Treatment Market, By Disease Type:
    • Anterior Uveitis
    • Posterior Uveitis
    • Intermediate Uveitis
    • Panuveitis
  • Global Uveitis Treatment Market, By Cause:
    • Infectious Uveitis
    • Non-Infectious Uveitis
  • Global Uveitis Treatment Market, By Geography:
    • North America
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Treatment:
        • Corticosteroids
        • Immunosuppressants
        • Monoclonal Antibodies
        • Cycloplegic Agents
        • Antibiotics
        • Antifungals
        • Antivirals
        • Analgesics
      • By Disease Type:
        • Anterior Uveitis
        • Posterior Uveitis
        • Intermediate Uveitis
        • Panuveitis
      • By Cause:
        • Infectious Uveitis
        • Non-Infectious Uveitis
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AbbVie, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Novartis AG
    • Eyegate Pharmaceuticals, Inc.
    • Santen Pharmaceuticals
    • Alimera Sciences
    • Regeneron Pharmaceuticals, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Allergan Plc

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Treatment
      • Market Snippet By Disease Type
      • Market Snippet By Cause
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • Pipeline Analysis
    • Novel Innovation in Uveitis Treatment
    • Epidemiology
  4. Global Uveitis Treatment Market, By Treatment, 2017 – 2025, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Immunosuppressant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Monoclonal Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Cycloplegic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Antivirals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Antifungal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  5. Global Uveitis Treatment Market, By Disease Type, 2017 - 2025, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Anterior Uveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Posterior Uveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Intermediate Uveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Panuveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  6. Global Uveitis Treatment Market, By Cause, 2017 - 2025, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Infectious Uveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Non- infectious Uveitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  7. Global Bone Graft and Substitutes Market, By Region, 2017 – 2025, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 - 2025
    • North America
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Santen Pharmaceutical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Regeneron Pharmaceuticals, Inc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Allergan Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Valeant Pharmaceutical International, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Abbvie, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Alimera Sciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
        •  
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 30 figures on “Global Uveitis Treatment Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.